drugset / Trial / NCT01922765
Concomitant Therapy of H. Pylori
Phase 4
Unknown
540 enrolled
The Catholic University of Korea
Bucheon St. Mary's Hospital · collabSt Vincent's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
If we compare eradication rate of Helicobacter pylori divided to 4 groups: amoxicillin, rabeprazole, clarithromycin(AOC), amoxicillin, rabeprazole, metronidazole(AOM), treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days(sequential), amoxicillin, clarithromycin, metronidazole, rabeprazole(concomitant), then the eradication rate of concomitant group will be the highest.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | — | — |
| Subject | Clarithromycin | Small molecule | — | — |
| Subject | Metronidazole | Small molecule | — | — |
| Subject | Rabeprazole | Small molecule | — | — |